GRIGUOLO, GAIA

GRIGUOLO, GAIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 96 (tempo di esecuzione: 0.047 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer 2026 Caire, RobinZanconato, FrancescaPanciera, TitoAudoux, EstelleContessotto, PaoloRomano, OrianaSuli, AmbelaBattilana, GiusyMarchionni, MatteoDieci, Maria VittoriaGriguolo, GaiaFassan, MatteoGuzzardo, VincenzaDei Tos, Angelo PaoloBicciato, SilvioGuarneri, ValentinaCordenonsi, Michelangelo + CELL - -
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort 2026 Griguolo, GaiaGuarneri, Valentina + THE BREAST - -
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 2026 Dieci, Maria VittoriaMenichetti, AliceGriguolo, GaiaGuarneri, ValentinaMariani, Luigi + BREAST - -
Proactive Brain Screening Using Contrast-Enhanced Brain CT Scans in HER2+ Metastatic Breast Cancer 2026 Gaia GriguoloMichele BottossoGiorgio BonomiFederica MigliettaMaria Vittoria DieciValentina Guarneri + CLINICAL CANCER RESEARCH - -
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications 2025 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaBicciato, SilvioTosi, AnnaSchiavi, FrancescaDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study 2025 Miglietta, F.Collesei, A.Griguolo, G.Massa, D.Fassan, M.Dei Tos, A. P.Dieci, M. V.Guarneri, V. + ESMO OPEN - -
Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes 2025 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaBonomi, GiorgioMassa, DavideDieci, Maria VittoriaGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications 2025 Griguolo, GDieci, M VBottosso, MMiglietta, FZanconato, FSchiavi, FFassan, MDei Tos, A PPiccolo, SGuarneri, V + ESMO OPEN - -
Health networking on cancer in the European Union: a ‘green paper’ by the EU Joint Action on Networks of Expertise (JANE) 2025 Griguolo, Gaia + ESMO OPEN - -
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis 2025 Valentina GuarneriMaria Vittoria DieciGaia Griguolo + THE LANCET ONCOLOGY - -
Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis 2025 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGriguolo, GaiaGuarneri, Valentina + THE BREAST - -
Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis 2025 Griguolo, GaiaDieci, Maria VittoriaGuarneri, Valentina + THE BREAST - -
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial 2025 Miglietta, FedericaGriguolo, GaiaMassa, DavideSchiavi, FrancescaFassan, MatteoDei Tos, Angelo PaoloGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study 2025 Dieci, M. V.Menichetti, A.Griguolo, G.Guarneri, V. + ANNALS OF ONCOLOGY - -
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 2025 Griguolo, GaiaGuarneri, Valentina + NPJ BREAST CANCER - -
Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumab 2025 Bonomi, GiorgioGriguolo, GaiaMiglietta, FedericaBottosso, MicheleDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -
Temporal evolution of breast cancer brain metastases treatments and outcomes 2025 Bottosso, MicheleGriguolo, GaiaMiglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 2024 Bottosso, MicheleDieci, Maria VittoriaMiglietta, FedericaBonanno, LauraGuarneri, ValentinaGriguolo, GaiaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer 2024 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, ValentinaGriguolo, Gaia + CLINICAL CANCER RESEARCH - -
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer 2024 Massa, DavideGriguolo, GaiaMiglietta, FedericaSchiavi, FrancescaFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + JOURNAL OF THE NATIONAL CANCER INSTITUTE - -